-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Emmaus Life Sciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Emmaus Life Sciences, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$1K, a 103% decline year-over-year.
- Emmaus Life Sciences, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$89K, a 229% decline year-over-year.
- Emmaus Life Sciences, Inc. annual Income Tax Expense (Benefit) for 2023 was -$59K, a 198% decline from 2022.
- Emmaus Life Sciences, Inc. annual Income Tax Expense (Benefit) for 2022 was $60K, a 140% increase from 2021.
- Emmaus Life Sciences, Inc. annual Income Tax Expense (Benefit) for 2021 was $25K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)